3
omas: is surgical removal beneficial. Am J Obstet Gynecol 2004;191(2):597–606 [discussion 606–7]. (10) 2006 Center for Disease Control National Report. http:// www.cdc.gov/ART/ART2006/index.htm. (11) Jacobs LA, Thie J, Patton PE, Williams TJ. Primary microsurgery for postinflammatory tubal infertility. Fertil Steril 1988;50:855–9. (12) Carey M, Brown S. Infertility surgery for pelvic inflammatory disease: success rates after salpingolysis and salpingostomy. Am J Obstet Gynecol 1987;156:296–300. (13) Benadiva CA, Kligman I, Davis O, Rosenwaks Z. In vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete? Fertil Steril 1995;64(6):1051–61. (14) Novy M, Thurmond AS, Patton P, et al. Diagnosis of corneal obstruction by transcervical fallopian tube cannulation. Fertil Steril 1988;50:434–40. (15) Woolcott R, Petchpud A, O’Donnell P, Stanger J. Differential impact on pregnancy rate of selective salpingography, tubal catheterization and wire-guide recanalization in the treatment of proximal fallopian tube obstruction. Hum Reprod 1995;10: 1423–1426. (16) Vandromme J, Chasse E, Lejeune B, et al. Hydrosalpinges in in vitro fertilization: an unfavourable prognostic feature. Hum Reprod 1995;10:576–9. (17) Strandell A, Waldenstro¨m U, Nilsson L, et al. Hydrosalpinx reduces in vitro fertilization/embryo transfer rates. Hum Reprod 1994;9:861–3. (18) Strandell A, Lindhard A, Waldenstro¨m U, Thorburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospec- tive, randomized multicentre trial in Scandinavia on salpingec- tomy prior to IVF. Hum Reprod 1999;14(11):2762–9. (19) Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv 2001;56(8):483–91. (20) Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006;22(2):106–9. (21) Rackow BW, Arici A. Fibroids and in vitro fertilization: which comes first? Curr Opin Obstet Gynecol 2005;17(3):225–31. (22) Surrey ES, Minjarez DA, Stevens JM, Schoolcraft WB. Effect of myomectomy on the outcome of assisted reproductive technolo- gies. Fertil Steril 2005;83(5):1473–9. [23) Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomar- asamy A. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 2010;25(2): 418–29. (24) Cagnacci A, Pirillo D, Malmusi S, Arangino S, Alessandrini C, Volpe A. Early outcome of myomectomy by laparotomy, minilaparotomy and laparoscopically assisted minilaparotomy. A randomized prospective study. Hum Reprod 2003;18(12): 2590–4. (25) Wen KC, Chen YJ, Sung PL, Wang PH. Comparing uterine fibroids treated by myomectomy through traditional laparotomy and 2 modified approaches: ultraminilaparotomy and laparo- scopically assisted ultraminilaparotomy. Am J Obstet Gynecol 2010;202(2):144.e1–8. Rony Abdallah * , Isaac Kligman The Center for Reproductive Medicine and Infertility, Weill Medical College of Cornell University, NewYork, NY, USA *Address: The Center for Reproductive Medicine and Infertility, Weill Medical College of Cornell University, M.D. 1305 York Avenue, New York, NY 10021, USA. Tel.: +1 646 962 2764. E-mail: [email protected] Comment by: Ahmed Nasr 1. Introduction Around the globe, gynecologists are far from reaching a unan- imous agreement about the role of laparoscopy in infertility management. Unanswered remains the all-important question of when to perform laparoscopy, if ever, in the infertility work- up. The currently available evidence generates a great deal of uncertainty, controversy, cynicism and skepticism among practicing gynecologists and infertility specialists. Pragmatic use of diagnostic laparoscopy for the evaluation of all cases of female infertility is a contentious issue. Ten years ago, al- most 90% of all reproductive endocrinologists in the USA rou- tinely performed a laparoscopy in the diagnostic work-up of infertility (1). However, in up to two thirds of women, no def- inite pathology was witnessed or only minimal and mild endo- metriosis (2). In the mid-1990’s, the test ‘diagnostic laparoscopy’ failed to be an ideal predictor for infertility (3). Consequently, routinely performing this procedure has been seriously challenged (4). In many IVF clinics worldwide, diag- nostic laparoscopy is increasingly bypassed in an endeavor not only to avoid potential complications but also to reduce costs (3). Strong advocates of the procedure highly praise laparos- copy as a gold standard diagnostic tool that can be combined with hysteroscopy and endometrial biopsy as part of day care surgery with the potential of performing both diagnosis and therapy. Counter-agonists, on the other hand, focus on other less invasive diagnostic substitutes as well as disadvantages including the need for general anesthesia, patient’s anxiety and the possibility of adhesion formation (3). With the swing of the pendulum, equipoise is still out of reach. 2. Could laparoscopy be reliably replaced by unconventional diagnostic procedures in the evaluation of tuboperitoneal infertility? Hysterosalpingography (HSG) has been classically used for decades for the evaluation of tuboperitoneal infertility. Hys- terosalpingo Contrast Sonography (HyCoSy) is an attractive ultrasonography-based tool for outpatient screening for tubal patency. Besides lack of exposure to X-rays or iodinated con- trast media, assessment of tubal patency was as good as con- ventional HSG (5). A new imaging technique called saline intraperitoneal sonogram (SIPS) has been demonstrated as a safe, quick, and potentially cost-effective method for evaluat- ing pelvic adhesive disease in an outpatient facility in women with unexplained infertility and a normal HSG (6). Dynamic MR-hysterosalpingography with cervical cannulation and intracavitary gadolinium injection has allowed assessment of the uterus, fallopian tubes, and extra-uterine pelvic structures, while avoiding all ionizing radiation (7). Based on symptoms suggestive of previous pelvic inflammatory disease (PID), a history of abnormal vaginal discharge and a previous diagno- sis of a lower genital tract infection, the positive predictive va- lue of thorough history taking, was only 56%, 59%, and 35%, respectively, in predicting tuboperitoneal infertility (3,8). Given the fact that Chlamydia trachomatis is the most impor- tant etiologic factor in PID, screening for Chlamydia antibod- 150 Debate

Is there a role of laparoscopy in the diagnosis and treatment of infertility in the 21st century?

Embed Size (px)

Citation preview

omas: is surgical removal beneficial. Am J Obstet Gynecol

2004;191(2):597–606 [discussion 606–7].

(10) 2006 Center for Disease Control National Report. http://

www.cdc.gov/ART/ART2006/index.htm.

(11) Jacobs LA, Thie J, Patton PE, Williams TJ. Primary microsurgery

for postinflammatory tubal infertility. Fertil Steril 1988;50:855–9.

(12) Carey M, Brown S. Infertility surgery for pelvic inflammatory

disease: success rates after salpingolysis and salpingostomy. Am J

Obstet Gynecol 1987;156:296–300.

(13) Benadiva CA, Kligman I, Davis O, Rosenwaks Z. In vitro

fertilization versus tubal surgery: is pelvic reconstructive surgery

obsolete? Fertil Steril 1995;64(6):1051–61.

(14) Novy M, Thurmond AS, Patton P, et al. Diagnosis of corneal

obstruction by transcervical fallopian tube cannulation. Fertil

Steril 1988;50:434–40.

(15) Woolcott R, Petchpud A, O’Donnell P, Stanger J. Differential

impact on pregnancy rate of selective salpingography, tubal

catheterization and wire-guide recanalization in the treatment of

proximal fallopian tube obstruction. Hum Reprod 1995;10:

1423–1426.

(16) Vandromme J, Chasse E, Lejeune B, et al. Hydrosalpinges in

in vitro fertilization: an unfavourable prognostic feature. Hum

Reprod 1995;10:576–9.

(17) Strandell A, Waldenstrom U, Nilsson L, et al. Hydrosalpinx

reduces in vitro fertilization/embryo transfer rates. Hum Reprod

1994;9:861–3.

(18) Strandell A, Lindhard A, Waldenstrom U, Thorburn J, Janson

PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospec-

tive, randomized multicentre trial in Scandinavia on salpingec-

tomy prior to IVF. Hum Reprod 1999;14(11):2762–9.

(19) Pritts EA. Fibroids and infertility: a systematic review of the

evidence. Obstet Gynecol Surv 2001;56(8):483–91.

(20) Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position

of fibroids on fertility. Gynecol Endocrinol 2006;22(2):106–9.

(21) Rackow BW, Arici A. Fibroids and in vitro fertilization: which

comes first? Curr Opin Obstet Gynecol 2005;17(3):225–31.

(22) Surrey ES, Minjarez DA, Stevens JM, Schoolcraft WB. Effect of

myomectomy on the outcome of assisted reproductive technolo-

gies. Fertil Steril 2005;83(5):1473–9.

[23) Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomar-

asamy A. The effect of intramural fibroids without uterine

cavity involvement on the outcome of IVF treatment: a

systematic review and meta-analysis. Hum Reprod 2010;25(2):

418–29.

(24) Cagnacci A, Pirillo D, Malmusi S, Arangino S, Alessandrini C,

Volpe A. Early outcome of myomectomy by laparotomy,

minilaparotomy and laparoscopically assisted minilaparotomy.

A randomized prospective study. Hum Reprod 2003;18(12):

2590–4.

(25) Wen KC, Chen YJ, Sung PL, Wang PH. Comparing uterine

fibroids treated by myomectomy through traditional laparotomy

and 2 modified approaches: ultraminilaparotomy and laparo-

scopically assisted ultraminilaparotomy. Am J Obstet Gynecol

2010;202(2):144.e1–8.

Rony Abdallah *, Isaac Kligman

The Center for Reproductive Medicine and Infertility,Weill Medical College of Cornell University,

NewYork,

NY, USA*Address: The Center for Reproductive Medicine and

Infertility, Weill Medical College of Cornell University,M.D. 1305 York Avenue, New York, NY 10021, USA.

Tel.: +1 646 962 2764.E-mail: [email protected]

150 Debate

Comment by: Ahmed Nasr

1. Introduction

Around the globe, gynecologists are far from reaching a unan-imous agreement about the role of laparoscopy in infertility

management. Unanswered remains the all-important questionof when to perform laparoscopy, if ever, in the infertility work-up. The currently available evidence generates a great deal of

uncertainty, controversy, cynicism and skepticism amongpracticing gynecologists and infertility specialists. Pragmaticuse of diagnostic laparoscopy for the evaluation of all cases

of female infertility is a contentious issue. Ten years ago, al-most 90% of all reproductive endocrinologists in the USA rou-tinely performed a laparoscopy in the diagnostic work-up ofinfertility (1). However, in up to two thirds of women, no def-

inite pathology was witnessed or only minimal and mild endo-metriosis (2). In the mid-1990’s, the test ‘diagnosticlaparoscopy’ failed to be an ideal predictor for infertility (3).

Consequently, routinely performing this procedure has beenseriously challenged (4). In many IVF clinics worldwide, diag-nostic laparoscopy is increasingly bypassed in an endeavor not

only to avoid potential complications but also to reduce costs(3). Strong advocates of the procedure highly praise laparos-copy as a gold standard diagnostic tool that can be combinedwith hysteroscopy and endometrial biopsy as part of day care

surgery with the potential of performing both diagnosis andtherapy. Counter-agonists, on the other hand, focus on otherless invasive diagnostic substitutes as well as disadvantages

including the need for general anesthesia, patient’s anxietyand the possibility of adhesion formation (3). With the swingof the pendulum, equipoise is still out of reach.

2. Could laparoscopy be reliably replaced by unconventional

diagnostic procedures in the evaluation of tuboperitoneal

infertility?

Hysterosalpingography (HSG) has been classically used fordecades for the evaluation of tuboperitoneal infertility. Hys-

terosalpingo Contrast Sonography (HyCoSy) is an attractiveultrasonography-based tool for outpatient screening for tubalpatency. Besides lack of exposure to X-rays or iodinated con-trast media, assessment of tubal patency was as good as con-

ventional HSG (5). A new imaging technique called salineintraperitoneal sonogram (SIPS) has been demonstrated as asafe, quick, and potentially cost-effective method for evaluat-

ing pelvic adhesive disease in an outpatient facility in womenwith unexplained infertility and a normal HSG (6). DynamicMR-hysterosalpingography with cervical cannulation and

intracavitary gadolinium injection has allowed assessment ofthe uterus, fallopian tubes, and extra-uterine pelvic structures,while avoiding all ionizing radiation (7). Based on symptoms

suggestive of previous pelvic inflammatory disease (PID), ahistory of abnormal vaginal discharge and a previous diagno-sis of a lower genital tract infection, the positive predictive va-lue of thorough history taking, was only 56%, 59%, and 35%,

respectively, in predicting tuboperitoneal infertility (3,8).Given the fact that Chlamydia trachomatis is the most impor-tant etiologic factor in PID, screening for Chlamydia antibod-

Debate 151

ies (by Chlamydia antibody testing or CAT) has been pro-posed as a primary screening tool for infertility due to tubalpathology (9). In endometriosis, however, the situation is more

vexing. Many women with pelvic endometriosis are symptom-free (10). Lack of satisfactory non-invasive tests for endometri-osis has given laparoscopy the credit of being the gold stan-

dard for diagnosis, preferably with histologic confirmation (11).

3. Role of laparoscopy in ovarian-factor infertility

There is a serious lack of evidence regarding routine use ofdiagnostic laparoscopy before the onset of ovulation inductiontreatment or after several failed ovulation induction cycles;

only few retrospective and non-controlled studies are avail-able. A recent Cochrane review concluded that laparoscopicovarian drilling (LOD) was a satisfactory second-line treat-

ment strategy in women with clomiphene citrate-resistantPCOS that proved to be as effective as gonadotropin treatmentwith similar live birth and miscarriage rates. Potential advan-tages of LOD over gonadotropins include ease and conve-

nience of the treatment, reduction in OHSS and multiplepregnancy rates, increased responsiveness of the ovary to oralovulation induction agents after the procedure, sustainability

of ovarian activity as evidenced by consecutive spontaneousovulations resulting years after LOD and the added value ofmaking a laparoscopic assessment of the pelvis (12).

4. Role of laparoscopy in endometriosis and pelvic adhesive

disease

In a recent Cochrane review, Jacobson and co-workers (13)concluded that use of laparoscopic surgery in the treatmentof subfertility related to minimal and mild endometriosis

may improve future fertility. However, no RCTs or meta-anal-yses are available for laparoscopic treatment of moderate andsevere endometriosis, albeit it is generally accepted that thoseshould be treated by surgery (10). A negative correlation be-

tween the stage of endometriosis and the spontaneous cumula-tive pregnancy rate (CPR) after surgical management has beenreported (3). Regarding laparoscopic adhesiolysis, only one

non-randomized controlled study documented higher CPRafter the procedure (14).

5. Laparoscopic myomectomy

Compared with laparotomy, laparoscopic myomectomy hasthe advantages of small incisions, short hospital stay, less post-

operative pain, rapid recovery and good assessment of otherabdominal organs. Laparoscopic myolysis causes severe adhe-sion formation. Laparoscopic myomectomy is still the besttreatment option for symptomatic women with uterine fibroids

who wish to maintain their fertility (15). Laparoscopic sutur-ing is more demanding. This can be overcome by robotic-as-sisted laparoscopic myomectomy (16).

6. Role of laparoscopy in assisted reproductive technology

(ART)

Tremendous advancements in ART have undoubtedly en-croached upon the role of reproductive surgery; some authors

strongly advocate immediate treatment with ART after a lim-ited and non-invasive infertility work-up in all patients (17).Two critical issues remain controversial. First, should the diag-

nostic infertility work-up be completed with a laparoscopyprior to ART? Second, what is the precise role of laparoscopyfollowing repeated ART failures? The vast majority of repro-

ductive surgeons do, however, agree that hydrosalpinx andovarian endometriotic cysts have to be managed laparoscopi-cally prior to IVF. Two RCTs have documented increased

implantation and pregnancy rates in IVF cycles after salpin-gectomy for ultrasonically visible hydrosalpinges; eight womenwould have to undergo salpingectomy prior to IVF to gain oneadditional live birth (18). In cervical factor, unexplained and

mild male infertility, IUI is an effective fertility enhancingtechnique. Contentious issues in the setting of IUI treatmentinclude the role of laparoscopy in tailoring and timing of treat-

ment plans, being performed prior to or only after several IUIfailures. Paucity of randomized trials addressing these issuescall for an urgent need for further randomized studies to come

up with plausible reproducible conclusions (19).

7. Conclusion

Pragmatic resort to laparoscopy for the evaluation and treat-ment of all cases of female infertility is currently controversial.Time has now come, more than ever before, for a rethink on

unrestricted use of the procedure in the eon of evidence-basedmedicine (EBM). Laparoscopy should not be considered ‘rou-tine’. Selective use is a policy that should be praised and

encouraged. This is particularly pertinent to developing na-tions, where any reduction in the overall cost and procedure-related morbidity has substantial repercussions. Whereas cur-rently available evidence indicates that laparoscopy might have

a beneficial and fertility enhancing impact in few clinical set-tings, its decisive role in many others is far from being evi-dence-based. The overwhelming need for further prospective

randomized studies to confirm or refute a potential benefitcould not be overemphasized. Moving on from theory to prac-tice, a competent gynecologist is expected to show a great deal

of expertise, and above all wisdom, when deciding to performa laparoscopy. I do recommend that every one of us asks him-self/herself one important question: is laparoscopy indispens-ably needed, or could we do equally well with less invasive

maneuvers? If so, should it be carried out right now?

References

(1) Glatstein IZ, Harlow BL, Hornstein MD. Practice patterns

among reproductive endocrinologists: the infertility evaluation.

Fertil Steril 1997;67:443–51.

(2) Forman RG, Robinson JN, Mehta Z, Barlow DH. Patient history

as a simple predictor of pelvic pathology in subfertile women.

Hum Reprod 1993;8:53–5.

(3) Bosteels J, Van Herendael B, Weyers S, D’Hooghe T. The

position of diagnostic laparoscopy in current fertility practice.

Hum Reprod Update 2007;13:477–85.

(4) Fatum M, Laufer N, Simon A. Investigation of the infertile

couple: should diagnostic laparoscopy be performed after normal

hysterosalpingography in treating infertility suspected to be of

unknown origin? Hum Reprod 2002;17:1–3.

(5) Hamilton J, Latarche E, Gillott C, Lower A, Grudzinskas JG.

Intrauterine insemination results are not affected if Hysterosal-

152 Debate

pingo Contrast Sonography is used as the sole test of tubal

patency. Fertil Steril 2003;80:165–71.

(6) Shah AA, Walmer DK. A feasibility study to evaluate pelvic

peritoneal anatomy with a saline intraperitoneal sonogram

(SIPS). Fertil Steril, in press.

(7) Winter L, Glucker T, Steimann S, Frohlich JM, Steinbrich W, De

Geyter C, Pegios W. Feasibility of dynamic MR-hysterosalpin-

gography for the diagnostic work-up of infertile women. Acta

Radiol 2010;51:693–701.

(8) Hubacher D, Grimes D, Lara-Ricalde R, de la Jara J, Garcia-

Luna A. The limited clinical usefulness of taking a history in the

evaluation of women with tubal factor infertility. Fertil Steril

2004;81:6–10.

(9) Mol BWJ, Collins JA, van der Veen F, Bossuyt PMM. Cost-

effectiveness of hysterosalpingography, laparoscopy and Chla-

mydia antibody testing in subfertile couples. Fertil Steril

2001;75:571–80.

(10) Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman

G, Greb R, Hummelshoj L, Prentice A, Saridogan E. ESHRE

guidelines for the diagnosis and treatment of endometriosis. Hum

Reprod 2005;20:2698–704.

(11) Hsu AL, Khachikyan I, Stratton P. Invasive and noninvasive

methods for the diagnosis of endometriosis. Clin Obstet Gynecol

2010;53:413–9.

(12) Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P.

Laparoscopic drilling by diathermy or laser for ovulation

induction in anovulatory polycystic ovary syndrome. Cochrane

Database Syst Rev 2005;3:CD001122.

(13) Jacobson TZ, Duffy JM, Barlow D, Farquhar C, Koninckx PR,

Olive D. Laparoscopic surgery for subfertility associated with

endometriosis. Cochrane Database Syst Rev 2010;1:CD001398.

(14) Tulandi T, Collins JA, Burrows E, Jarrell JF, McInnes RA,

Wrixon W. Treatment-dependent and treatment-independent

pregnancy among women with periadnexal adhesions. Am J

Obstet Gynecol 1990;162:354–7.

(15) Agdi M, Tulandi T. Endoscopic management of uterine fibroids.

Best Pract Res Clin Obstet Gynaecol 2008;22:707–16.

(16) Agdi M, Tulandi T. Minimally invasive approach for myomec-

tomy. Semin Reprod Med 2010;28:228–34.

(17) Speroff L,GlassRH,KaseNG.Female infertility. In: Speroff L,Glass

RH, Kase NG, editors. Clinical gynaecologic endocrinology and

infertility. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.

(18) Johnson NP, Mak W, Sowter MC. Surgical treatment for tubal

disease in women due to undergo in vitro fertilization. Cochrane

Database Syst Rev 2004;3:CD002125.

(19) Tanahatoe SJ, Lambalk CB, Hompes PGA. The role of laparos-

copy in intrauterine insemination: a prospective randomized

reallocation study. Hum Reprod 2005;20:3225–30.

Ahmed Nasr

Women’s Health Center, Dept. of Obstetrics and Gynecology,Faculty of Medicine, Assiut University,

P.O. Box 1, 71516 Assiut, Egypt

Tel.: +20 10 5212140/88 2185437; fax: +20 88 2368377.E-mail: [email protected]